» Articles » PMID: 2064486

Does Racial Variation in Risk Factors Explain Black-white Differences in the Incidence of Hypertensive End-stage Renal Disease?

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 1991 Jul 1
PMID 2064486
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Prospectively collected data on the incidence of treated hypertensive end-stage renal disease (HT-ESRD) were analyzed to investigate whether the higher rate of HT-ESRD in blacks compared with whites is due to differences in putative ESRD risk factors. The overall age-adjusted relative risks of HT-ESRD for black compared with white residents in the Maryland Regional ESRD Registry (Network 31) Catchment Area were 7.4 (95% confidence interval, 5.9 to 9.4) and 9.9 (95% confidence interval, 7.4 to 13.1) for men and women, respectively. In a population level analysis, race-specific HT-ESRD incidence rates in the black and white populations of 13 regions in Network 31 were related to the prevalence of putative ESRD risk factors in those populations. The latter were estimated from the 1981-1982 Maryland Statewide Household Hypertension Survey. Black populations had a 5.6-fold (95% confidence interval, 3.9 to 8.1) higher unadjusted incidence of HT-ESRD than white populations. The HT-ESRD incidence in a population was also directly related to that population's prevalence of hypertension, severe hypertension, and diabetes mellitus and inversely related to measures of socioeconomic status and mean age at diagnosis of hypertension. When adjusted simultaneously for age, prevalence of hypertension, severe hypertension, diabetes, and level of education, the risk of HT-ESRD was still 4.5 (95% confidence interval, 3.2 to 6.2) times higher for black compared with white populations. Our findings failed to support the hypothesis that race-related differences in the prevalence, severity, or age at onset of hypertension, in the prevalence of diabetes or in socioeconomic status, explain the well-recognized black-white differences in the HT-ESRD incidence.

Citing Articles

Metabolic Responses of Normal Rat Kidneys to a High Salt Intake.

Shimada S, Hoffmann B, Yang C, Kurth T, Greene A, Liang M Function (Oxf). 2023; 4(5):zqad031.

PMID: 37575482 PMC: 10413938. DOI: 10.1093/function/zqad031.


Neighborhood context and kidney disease in Philadelphia.

Boyle S, Zhao Y, Chou E, Moore K, Harhay M SSM Popul Health. 2020; 12:100646.

PMID: 32939392 PMC: 7476869. DOI: 10.1016/j.ssmph.2020.100646.


Therapeutic Suppression of mTOR (Mammalian Target of Rapamycin) Signaling Prevents and Reverses Salt-Induced Hypertension and Kidney Injury in Dahl Salt-Sensitive Rats.

Kumar V, Evans L, Kurth T, Yang C, Wollner C, Nasci V Hypertension. 2019; 73(3):630-639.

PMID: 30595123 PMC: 6374175. DOI: 10.1161/HYPERTENSIONAHA.118.12378.


Primary prevention of chronic kidney disease through population-based strategies for blood pressure control: The ARIC study.

Hardy S, Zeng D, Kshirsagar A, Viera A, Avery C, Heiss G J Clin Hypertens (Greenwich). 2018; 20(6):1018-1026.

PMID: 29797488 PMC: 6528649. DOI: 10.1111/jch.13311.


Race/Ethnicity, Dietary Acid Load, and Risk of End-Stage Renal Disease among US Adults with Chronic Kidney Disease.

Crews D, Banerjee T, Wesson D, Morgenstern H, Saran R, Burrows N Am J Nephrol. 2018; 47(3):174-181.

PMID: 29525790 PMC: 5906156. DOI: 10.1159/000487715.